OSTEOLYTIC LESIONS, HYPERCALCAEMIA AND BONE PAIN ASSOCIATED WITH SKELETAL METASTASES IN PATIENTS WITH BREAST CANCER OR MULTIPLE MYELOMA, BY MOUTH, 1.6 G DAILY IN SINGLE OR 2 DIVIDED DOSES INCREASED IF NECESSARY TO A MAX. OF 3.2 G DAILY
HYPERCALCAEMIA OF MALIGNANCY, BY SLOW INTRAVENOUS INFUSION, 300 MG DAILY FOR MAX. 7-10 DAYS OR BY SINGLE-DOSE INFUSION OF 1.5 G